Kusal Samarasinghe
@kusalTGSAM
Postdoc @Yale 🇱🇰 🇺🇸
ID:1126635001355866112
09-05-2019 23:48:10
75 Tweets
89 Followers
573 Following
I wish I heard this George Church (george church) podcast episode when I was a grad student!
1. You can change the world, as long as you don't care who gets credit.
2. The idea is not to never fail, it is to fail a million times a day.
3. Embrace the outlier!
nightscience.buzzsprout.com/1744020/149731…
Vividion Therapeutics Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase | Nature nature.com/articles/s4158…
Fascinating talk by Craig Crews on faculty entrepreneurship, and the long and winding journey of drug development… 🙌🏽👏🏽
Yale Pathology
Yale Ventures
Yale Cancer Center
Arvinas
CT Innovations
Great to see Susan Tsai, MD, MHS paper on the cover of Gastroenterology
Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for #PancreaticCancer
Congratulations Sue!
gastrojournal.org/article/S0016-…
Meet Cigall Kadoch of @HarvardMed who knows everything about Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Disease. And guess what? You can hear all about it at our 60th Anniversary Symposium! #MPIMG60years Register now👇
molgen.mpg.de/60th-anniversa…
Interdisciplinary collaboration can create external analytical advocates, helping repair the field’s reputation problem, says Ben Garcia 💭👇🏼
bit.ly/3OSN3aA
During #DrugDiscoveryDay Ryan Cross the Science Boss had an in-depth discussion with Arena BioWorks co-founder Stuart Schreiber around small molecule drug discovery, AI in chemical biology, & new models of funding science. Watch this conversation & more On Demand: bit.ly/44503Ak
Check out this Brad Loncar BiotechTV interview with Chaitan Khosla, director of the Innovative Medicines Accelerator (IMA) Stanford Medicine, with a pipeline of drug dev programs available for partnering/licensing:
ima.stanford.edu
Can we conjugate ubiquitin in a non-canonical fashion? Join Breanna Zerfas and me for two compelling seminars at 11 am EDT, 8 am PT, 4 pm BST, 5 pm CEST: Jonathan Ostrem: “Direct Small Molecule Ubiquitination”
Darci Trader: “Bypassing an E3 Ligase for TPD'